Assertio Holdings Inc

-0.18 (-7.72%)
5:08:10 PM EDT: $2.15 0.00 (0.00%)
Positive Earnings Pre-Announcement, Mergers / Acquisitions

Assertio Holdings Announces Acquisition Of Otrexup

Published: 12/15/2021 22:56 GMT
Assertio Holdings Inc (ASRT) - Assertio Holdings, Inc. Announces the Acquisition of Otrexup® (methotrexate) a Drug Device Combination From Antares Pharma, Inc.assertio Holdings Inc - Raises Full Year Net Product Sales and Non-GAAP Adjusted EBITDA Guidance.
Assertio Holdings Inc - Acquired Otrexup From Antares in a Partially Seller Financed Transaction for a Total Purchase Price of $44.0 Million.
Assertio Holdings Inc - Sees 2021 Full Year Net Product Sales Greater Than $108 Million.
Assertio Holdings Inc - Will Pay Antares $18.0 Million Upfront and an Additional $26.0 Million in Deferred Payments.
Assertio Holdings Inc - Acquisition Will Be Accretive to Adjusted EBITDA in 2022.
Revenue is expected to be $25.95 Million
Adjusted EPS is expected to be $0.08

Next Quarter Revenue Guidance is expected to be $26.27 Million
Next Quarter EPS Guidance is expected to be $0.08

More details on our Analysts Page.